Identification and analysis of papillomavirus E2 protein binding sites in the human genome

Journal of Virology

Volumn 86, Issue 1, 2012, Pages 348-357

  Võsa, Liisi ^a   Sudakov, Aleksander ^a   Remm, Maido ^a   Ustav, Mart ^a   Kurg, Reet ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

PAPILLOMAVIRUS E2 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL SPECIFICITY; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN PAPILLOMAVIRUS TYPE 11; IN VIVO CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY DNA SEQUENCE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION;

BINDING SITES; CELL LINE; CHROMATIN; GENOME, HUMAN; HUMAN PAPILLOMAVIRUS 11; HUMANS; NUCLEAR PROTEINS; PAPILLOMAVIRUS INFECTIONS; PROTEIN BINDING; REPETITIVE SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 11; PAPILLOMAVIRIDAE;

EID: 84855953902     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05606-11     Document Type: Article

References (56)

1. Akgül B, et al. 2011. The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures. Med. Microbiol. Immunol. 200(2): 127-135.
2. Alexander KA, Phelps WC. 1996. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites. Biochemistry 35:9864-9872.
3. Androphy EJ, Lowy DR, Schiller JT. 1987. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325:70-73.
4. Baker CC, et al. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:962-971.
5. Bastien N, McBride AA. 2000. Interaction of the papillomavirus E2 protein with mitotic chromosomes. Virology 270:124-134.
6. Behren A, et al. 2005. Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. Cancer Res. 65: 11613-11621.
7. Benson G. 1999. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27:573-580.
8. Burns JE, Walker HF, Schmitz C, Maitland NJ. 2010. Phenotypic effects of HPV-16 E2 protein expression in human keratinocytes. Virology 401: 314-321.
9. Canaan A, et al. 2009. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc. Natl. Acad. Sci. U. S. A. 106:22421-22426.
10. Chiang CM, Dong G, Broker TR, Chow LT. 1992. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins. J. Virol. 66:5224-5231.
11. Chin MT, Hirochika R, Hirochika H, Broker TR, Chow LT. 1988. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies. J. Virol. 62:2994-3002.
12. Dell G, et al. 2003. Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus. J. Mol. Biol. 334:979-991.
13. Demeret C, Desaintes C, Yaniv M, Thierry F. 1997. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71:9343-9349.
14. Dong G, Broker TR, Chow LT. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol. 68: 1115-1127.
15. Ferreiro DU, Dellarole M, Nadra AD, de Prat-Gay G. 2005. Free energy contributions to direct readout of a DNA sequence. J. Biol. Chem. 280: 32480-32484.
16. Flicek P, et al. 2010. Ensembl's 10th year. Nucleic Acids Res. 38: D557-D562.
17. Frattini MG, Hurst SD, Lim HB, Swaminathan S, Laimins LA. 1997. Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. EMBO J. 16:318-331.
18. Giri I, Yaniv M. 1988. Structural and mutational analysis of E2 transactivating proteins of papillomaviruses reveals three distinct functional domains. EMBO J. 7:2823-2829.
19. Hegde RS, Grossman SR, Laimins LA, Sigler PB. 1992. Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359:505-512.
20. Hines CS, et al. 1998. DNA structure and flexibility in the sequencespecific binding of papillomavirus E2 proteins. J. Mol. Biol. 276:809-818.
21. Hirochika H, Hirochika R, Broker TR, Chow LT. 1988. Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins. Genes Dev. 2:54-67.
22. Horner SM, DiMaio D. 2007. The DNA binding domain of a papillomavirus E2 protein programs a chimeric nuclease to cleave integrated human papillomavirus DNA in HeLa cervical carcinoma cells. J. Virol. 81: 6254-6264.
23. Ilves I, Kivi S, Ustav M. 1999. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites. J. Virol. 73:4404-4412.
24. Jang MK, Kwon D, McBride AA. 2009. Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J. Virol. 83:2592-2600.
25. Jiang M, Milner J. 2002. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21:6041-6048.
26. Johung K, Goodwin EC, DiMaio D. 2007. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J. Virol. 81: 2102-2116.
27. Kadaja M, et al. 2007. Genomic instability of the host cell induced by the human papillomavirus replication machinery. EMBO J. 26:2180-2191.
28. Kim SS, Tam JK, Wang AF, Hegde RS. 2000. The structural basis of DNA target discrimination by papillomavirus E2 proteins. J. Biol. Chem. 275: 31245-31254.
29. Kurg R, et al. 1999. Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication. J. Virol. 73: 4670-4677.
30. Kurg R, Sild K, Ilves A, Sepp M, Ustav M. 2005. Association of bovine papillomavirus E2 protein with nuclear structures in vivo. J. Virol. 79: 10528-10539.
31. Kurg R, Uusen P, Vosa L, Ustav M. 2010. Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. Virology 408:159-166.
32. Lee AY, Chiang CM. 2009. Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J. Biol. Chem. 284:2778-2786.
33. Lee D, et al. 2002. Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter. J. Biol. Chem. 277: 27748-27756.
34. Li R, Knight J, Bream G, Stenlund A, Botchan M. 1989. Specific recognition nucleotides and their DNA context determine the affinity of E2 protein for 17 binding-sites in the Bpv-1 genome. Genes Dev. 3:510-526.
35. Lister R, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315-322.
36. Lu F, et al. 2010. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr virus nuclear antigen 1 (EBNA1). Virol. J. 7:262.
37. Matsumoto T, Nakashima N, Takase K, Hirochika H, Mizuno H. 1997. A mutation study of the DNA binding domain of human papillomavirus type11 E2 protein. J. Biochem. 121:138-144.
38. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA. 2006. Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J. Virol. 80:9530-9543.
39. Meissner JD. 1999. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80(Pt. 7):1725-1733.
40. Mole S, Milligan SG, Graham SV. 2009. Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF. J. Virol. 83:357-367.
41. Oldak M, et al. 2010. Human papillomavirus type 8 E2 protein unravels JunB/Fra-1 as an activator of the beta4-integrin gene in human keratinocytes. J. Virol. 84:1376-1386.
42. Oldak M, et al. 2004. The human papillomavirus type 8 E2 protein suppresses beta4-integrin expression in primary human keratinocytes. J. Virol. 78:10738-10746.
43. Phelps WC, Howley PM. 1987. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J. Virol. 61:1630-1638.
44. Robin S, Schbath S, Vandewalle V. 2007. Statistical tests to compare motif count exceptionalities. BMC Bioinformatics 8:84.
45. Sánchez IE, Dellarole M, Gaston K, de Prat Gay G. 2008. Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics. Nucleic Acids Res. 36:756-769.
46. Sayers EW, et al. 2011. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 39:D38-D51.
47. Silla T, Mannik A, Ustav M. 2010. Effective formation of the segregationcompetent complex determines successful partitioning of the bovine papillomavirus genome during cell division. J. Virol. 84:11175-11188.
48. Smith JA, et al. 2010. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. U. S. A. 107:3752-3757.
49. Spalholz BA, Byrne JC, Howley PM. 1988. Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1. J. Virol. 62:3143-3150.
50. Spalholz BA, Yang YC, Howley PM. 1985. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product. Cell 42:183-191.
51. Tan SH, Leong LE, Walker PA, Bernard HU. 1994. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:6411-6420.
52. Thain A, Jenkins O, Clarke AR, Gaston K. 1996. CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J. Virol. 70:7233-7235.
53. Ustav M, Stenlund A. 1991. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 10:449-457.
54. Wu SY, Chiang CM. 2007. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 282: 13141-13145.
55. Wu SY, et al. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev. 20:2383-2396.
56. Yang A, et al. 2006. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell 24:593-602.